MoneyWorks4Me

Zim Laboratories - Quaterly Results

03 Feb 2023 Evaluate
The Revenue for the quarter ended  December 2022 of Rs. 1003.16 millions grew by 16.62 % from Rs. 860.20 millions.The company has announced a 49.86% increase in its profits to Rs . 65.70  millions for the  quarter ended December 2022 compared to Rs. 43.84 millions in the corresponding quarter in the previous year.Operating profit surged to 150.60 millions from the corresponding previous quarter of 113.61 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1003.16 860.20 16.62 2920.83 2253.86 29.59 3294.94 3036.29 8.52
Other Income 24.21 7.21 235.78 57.32 28.59 100.49 45.06 24.49 83.99
PBIDT 150.60 113.61 32.56 418.71 271.12 54.44 424.40 392.62 8.09
Interest 16.16 17.50 -7.66 43.05 68.75 -37.38 83.06 108.86 -23.70
PBDT 134.44 96.11 39.88 375.66 202.37 85.63 341.34 231.95 47.16
Depreciation 35.57 35.31 0.74 115.51 109.60 5.39 148.37 146.14 1.53
PBT 98.87 60.80 62.62 260.15 92.77 180.42 192.97 85.81 124.88
TAX 33.17 16.96 95.58 81.47 27.05 201.18 62.84 29.64 112.01
Deferred Tax 14.81 6.99 111.87 34.87 12.23 185.12 28.84 29.47 -2.14
PAT 65.70 43.84 49.86 178.68 65.72 171.88 130.13 56.17 131.67
Equity 487.26 162.42 200.00 487.26 162.42 200.00 162.42 162.42 0.00
PBIDTM(%) 15.01 13.21 13.67 14.34 12.03 19.17 12.88 12.93 -0.39
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..